BioSpace News Archive

First Digital Platform to Deliver Multiple Health Care Services to Your Door

Leading philanthropists have set up a $105 million fund to help end a disease that has plagued humanity since antiquity.

The company signed an exclusive worldwide options and licensing agreement with Japanese giant ‘Astellas Pharma’ for the development and acquisition of Juventas’s technological applications - contingent on clinical trial milestone successes

ZANTHOSYN® #1 AT GNC STORES IN HAWAII FOR PAST 12 MONTHS

Bayer announced today that the Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Artificial Intelligence (AI) Pattern Recognition Software, which Bayer is currently developing jointly with Merck, known as MSD outside the U.S. and Canada.

Cidara Therapeutics today announced the appointments of James Levine as chief financial officer and Jessica Oien, J.D., as general counsel and secretary.

Highly-experienced medical oncology experts providing superior cancer drug development strategy and expertise

The transactions were completed after the closing of markets on November 30, 2018.

Each year, as many as 20,000 young people “age out” of the foster care system many without strong family relationships or community connections to help them navigate their lives ahead.